Epstein Secrets

ounting firm Mazars USA is `wildly overboard,' and is not remotely confined to the grand jury investigation that began in 2018' at the direction of Vance." The filing argued that "the subpoena demands voluminous documents that relate to topics and entities far beyond the District Attorney's limited ju

program to reimburse pharmacies for dispensing a prescription medication." The Chronicle adds, "Between approximately February 2017 and July 2018, Khaimov and his co-conspirators submitted claims for approximately $6.9 million in reimbursements under the program, for medications the pharmacies operated

counting firm Mazars USA is 'wildly overboard; and 'is not remotely confined to the grand jury investigation that began in 2018' at the direction of Vance." The filing argued that "the subpoena demands voluminous documents that relate to topics and entities far beyond the District Attorney's limited j

program to reimburse pharmacies for dispensing a prescription medication." The Chronicle adds, "Between approximately February 2017 and July 2018, Khaimov and his co-conspirators submitted claims for approximately $6.9 million in reimbursements under the program, for medications the pharmacies operated

counting firm Mazars USA is `wildly overboard; and 'is not remotely confined to the grand jury investigation that began in 2018' at the direction of Vance." The filing argued that "the subpoena demands voluminous documents that relate to topics and entities far beyond the District Attorney's limited j

mburse pharmacies for dispensing a prescription medication." The Chronicle adds, "Between approximately February 2017 and July 2018, EFTA01658086 Khaimov and his co-conspirators submitted claims for approximately $6.9 million in reimbursements under the program, for medications the pharmacies operated